Zura Bio Ltd Ordinary Shares - Class A ZURA
News
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation